Cargando…

Correction: Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986949/ https://www.ncbi.nlm.nih.gov/pubmed/33741733 http://dx.doi.org/10.1136/jitc-2020-002058corr1

Ejemplares similares

Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis
por: Zou, Fangwen, et al.
Publicado: (2021)

Fecal calprotectin is an early predictor of endoscopic response and histologic remission after the start of vedolizumab in inflammatory bowel disease
por: Pauwels, Renske W. M., et al.
Publicado: (2020)

Fecal calprotectin as a noninvasive test to predict deep remission in patients with ulcerative colitis
por: Malvão, Ludimilla dos Reis, et al.
Publicado: (2021)

Association of Fecal Calprotectin With Endoscopic and Histologic Activity in Pediatric Inflammatory Bowel Disease
por: Crawford, Erin, et al.
Publicado: (2021)

Can fecal calprotectin accurately identify histological activity of ulcerative colitis? A meta-analysis
por: Ye, Xiaoqi, et al.
Publicado: (2021)

Fecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis
por: Kawashima, Kousaku, et al.
Publicado: (2016)

Diagnostic Value of Fecal Calprotectin in Patient with Ulcerative Colitis
por: Zamani, Hamed, et al.
Publicado: (2013)

The Utility of Fecal Calprotectin in the Diagnosis and Management of Microscopic Colitis
por: Songtanin, Busara, et al.
Publicado: (2023)

Correction to: Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
por: Abu-Sbeih, Hamzah, et al.
Publicado: (2019)

Fecal Immunochemical Test and Fecal Calprotectin Measurement Are Noninvasive Monitoring Tools for Predicting Endoscopic Activity in Patients with Ulcerative Colitis
por: Chang, Ji Young, et al.
Publicado: (2018)

Analysis of Endoscopic Evaluation Reliability for Ulcerative Colitis in Histological Remission
por: Kanazawa, Mimari, et al.
Publicado: (2021)

Assessing Histological Inflammatory Activity in Patients With Ulcerative Colitis: A Diagnostic Accuracy Study Testing Fecal Biomarkers Lactoferrin and Calprotectin
por: Langhorst, Jost, et al.
Publicado: (2020)

Correlation between fecal calprotectin, ulcerative colitis endoscopic index of severity and clinical outcome in patients with acute severe colitis
por: Ma, Rong, et al.
Publicado: (2020)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
por: Kim, Dong Ju, et al.
Publicado: (2018)

Fecal calprotectin concentration in neonatal necrotizing enterocolitis
por: Yoon, Jung Min, et al.
Publicado: (2014)

Fecal Calprotectin Concentrations in Cats with Chronic Enteropathies
por: Riggers, Denise S., et al.
Publicado: (2023)

Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes
por: Vieira, Andrea, et al.
Publicado: (2009)

Fecal Calprotectin and Clinical Disease Activity in Pediatric Ulcerative Colitis
por: Kolho, Kaija-Leena, et al.
Publicado: (2013)

Capabilities of fecal calprotectin and blood biomarkers as surrogate endoscopic markers according to ulcerative colitis disease type
por: Sonoyama, Hiroki, et al.
Publicado: (2019)

Association of endoscopic and histological remission with clinical course in patients of ulcerative colitis
por: Narang, Vikram, et al.
Publicado: (2018)

Possible Correlation between Giardia duodenalis Genotypes and Fecal Calprotectin in Children with Diarrhea
por: Abou-Seri, Hanan M, et al.
Publicado: (2022)

A54 DIETARY COMPONENTS ARE ASSOCIATED WITH FECAL CALPROTECTIN IN ULCERATIVE COLITIS
por: Chiu, E, et al.
Publicado: (2022)

High levels of fecal calprotectin and C-reactive protein in patients with colitis
por: Anindita, Brinna, et al.
Publicado: (2023)

Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis
por: Lee, Sun-Ho, et al.
Publicado: (2017)

Clinical implications of fecal calprotectin and fecal immunochemical test on mucosal status in patients with ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2019)

Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease
por: Gauss, Annika, et al.
Publicado: (2016)

Correction: Relevance of TNBS-Colitis in Rats: A Methodological Study with Endoscopic, Histologic and Transcriptomic Characterization and Correlation to IBD
Publicado: (2014)

Correction: Relevance of TNBS-Colitis in Rats: A Methodological Study with Endoscopic, Histologic and Transcriptomic Characterization and Correlation to IBD
por: Brenna, Øystein, et al.
Publicado: (2013)

Fecal Immunochemical Test and Fecal Calprotectin Results Show Different Profiles in Disease Monitoring for Ulcerative Colitis
por: Hiraoka, Sakiko, et al.
Publicado: (2018)

Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis
por: Urushikubo, Jun, et al.
Publicado: (2018)

Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative Colitis
por: Chen, Fang, et al.
Publicado: (2021)

Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis
por: Kamat, Nagesh, et al.
Publicado: (2022)

Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease: Erratum
Publicado: (2016)

Fecal Filobasidium Is Associated with Clinical Remission and Endoscopic Response following Fecal Microbiota Transplantation in Mild-to-Moderate Ulcerative Colitis
por: van Thiel, Isabelle A. M., et al.
Publicado: (2022)

Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome
por: Toyonaga, Takahiko, et al.
Publicado: (2017)

Comparison of fecal pyruvate kinase isoform M2 and calprotectin in acute diarrhea in hospitalized children
por: Czub, Elzbieta, et al.
Publicado: (2014)

Fecal Calprotectin Is Increased in Stroke
por: Park, Shin Young, et al.
Publicado: (2021)

Fecal Calprotectin Concentrations in Healthy Children Aged 1-18 Months
por: Li, Feng, et al.
Publicado: (2015)

Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome
por: von Arnim, Ulrike, et al.
Publicado: (2016)

Optimal cut‐off value of fecal calprotectin for the evaluation of ulcerative colitis: An unsolved issue?
por: Jha, Ashish Kumar, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ur1rs3sgveuhm0g9tp1v63og71